Literature DB >> 16151565

Outcomes of febrile children presumed to be immunocompetent who present with leukopenia or neutropenia to an ambulatory setting.

J R Serwint1, M M Dias, H Chang, M Sharkey, A R Walker.   

Abstract

UNLABELLED: To determine significant medical outcomes in febrile children presenting to an ambulatory setting with neutropenia and/or leukopenia.
METHODS: Retrospective medical record review conducted on febrile patients who had a blood culture drawn, with white blood cell counts less than 5,000/mm3 and/or an absolute neutrophil count less than 1000/mm3. Ninety-one patients were identified; 5 with positive blood culture results, 13 with significant non-oncologic disease, and 3 patients with leukemia who had involvement of 2 or more cell lines.
CONCLUSIONS: In the majority of patients, clinical judgment, physical findings, and review of all cell lines of the complete blood cell count identified those with significant disease.

Entities:  

Mesh:

Year:  2005        PMID: 16151565     DOI: 10.1177/000992280504400707

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  3 in total

1.  Evidence for infection, inflammation and shock in sudden infant death: parallels between a neonatal rat model of sudden death and infants who died of sudden infant death syndrome.

Authors:  Jane Blood-Siegfried; Caroline Rambaud; Abraham Nyska; Dori R Germolec
Journal:  Innate Immun       Date:  2008-06       Impact factor: 2.680

2.  Transient neutropenia in children with febrile illness and associated infectious agents: 2 years' follow-up.

Authors:  Ourania Alexandropoulou; Lydia Kossiva; Fotis Haliotis; Maria Giannaki; Maria Tsolia; I P Panagiotou; Kyriaki Karavanaki
Journal:  Eur J Pediatr       Date:  2013-02-14       Impact factor: 3.183

3.  Outcomes and infectious etiologies of febrile neutropenia in non-immunocompromised children who present in an emergency department.

Authors:  C Pascual; V Trenchs; S Hernández-Bou; A Català; A F Valls; C Luaces
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-18       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.